Chikungunya virus E2 protein rabbit monoclonal antibody and application thereof
A monoclonal antibody and protein technology, applied in the direction of antiviral immunoglobulin, antibody, antiviral agent, etc., can solve the problem of no effective therapeutic drugs and vaccines
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0039] The implementation of the present invention will be described in detail below in conjunction with the embodiments of the present invention and the accompanying drawings. The following embodiments are implemented on the premise of the technical solution of the present invention, and specific implementation methods and operating procedures are provided, but the protection of the present invention The scope is not limited to the examples described below. All operations related to the CHIKV virus in the present invention are carried out in the three-level biosafety laboratory of the Navy Military Medical University of the Chinese People's Liberation Army.
[0040] 1. Main experimental materials
[0041] 1. CHIKV E2 protein, the ECSA-type CHIKV E2 protein recombinantly expressed by human embryonic kidney 293T cells, is recombinantly expressed by freestyle293F cells grown in suspension culture in serum-free medium by the Biomedical Protection Teaching and Research Office of the...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com